Myriad Genetics
MYGN
MYGN
223 hedge funds and large institutions have $2.25B invested in Myriad Genetics in 2024 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 72 increasing their positions, 64 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
13% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 64
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.54% less ownership
Funds ownership: 104.41% → 101.87% (-2.5%)
Holders
223
Holding in Top 10
1
Calls
$4.84M
Puts
$3.1M
Top Buyers
| 1 | +$18.9M | |
| 2 | +$10.3M | |
| 3 | +$8.72M | |
| 4 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$7.91M |
| 5 |
Millennium Management
New York
|
+$7.13M |
Top Sellers
| 1 | -$46.8M | |
| 2 | -$26.2M | |
| 3 | -$23.3M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$14.7M |
| 5 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$9.51M |